Novo Nordisk – DB

Ahdoot & Wolfson is investigating a possible class action lawsuit against Novo Nordisk, following reports of a large data breach. Recently, there was an alleged cybersecurity incident involving Novo Nordisk. The alleged breach potentially exposed patient data related to certain clinical trials. The incident has raised concerns about data security and prompted investigations into the impact on affected patients.

• Compromised Data Volume: Pending investigation.
• Patient Information: Possibly including patient identification numbers, year of birth, sex, biomarkers, health information, immunogenicity data, and lifestyle factors.
• Clinical Trial Records: Information related to participation in certain Novo Nordisk clinical trials.
• Operational Documents: Internal records and other information currently under investigation.
• Potential Risks: Increased risk of privacy concerns and unauthorized access to sensitive health-related information.

If you participated in a Novo Nordisk clinical trial and received a data breach notification, your information may have been involved in a recent data breach. Please fill out the form below, and one of our attorneys will contact you promptly.